How LCZ696 API is Reshaping Cardiovascular Drug Development
Cardiovascular disease remains one of the leading causes of death globally, driving an urgent need for innovative therapies. One such breakthrough in recent years has been LCZ696, known generically as Sacubitril/Valsartan. This combination drug, deve...
